These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36765510)

  • 41. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center.
    Song Y; Wang J; Wang Y; Wang Z
    Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diagnostic significance of Th1/Th2 cytokine pattern in childhood hemophagocytic lymphohistiocytosis].
    Xu XJ; Tang YM; Zhao N; Song H; Yang SL; Shi SW; Xu WQ; Pan BH; Zhang LY; Mao JQ; Shen HP; Gu ME; Xia J
    Zhonghua Er Ke Za Zhi; 2011 Sep; 49(9):685-9. PubMed ID: 22176904
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical significance of cerebrospinal fluid soluble CD25 in pediatric hemophagocytic lymphohistiocytosis with central nervous system involvement.
    Ou W; Ma H; Wei A; Zhao Y; Zhang L; Lian H; Zhang Q; Chen S; Wang D; Li Z; Zhang R; Wang T
    Pediatr Blood Cancer; 2022 Aug; 69(8):e29712. PubMed ID: 35441804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical significance and different strategies for re-elevation of plasma EBV-DNA during treatment in pediatric EBV-associated hemophagocytic lymphohistiocytosis.
    Zhang W; Peng Y; Qiu Y; Cheng L; Yin Y; Li Y; Zhao L; Wu X
    J Pediatr (Rio J); 2024; 100(5):505-511. PubMed ID: 38604242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Los Angeles County.
    Kelesidis T; Humphries R; Terashita D; Eshaghian S; Territo MC; Said J; Lewinski M; Currier JS; Pegues D
    J Med Virol; 2012 May; 84(5):777-85. PubMed ID: 22431026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytokine profiles in Mycoplasma pneumoniae infection-associated hemophagocytic lymphohistiocytosis.
    Yasutomi M; Okazaki S; Hata I; Tanizawa A; Tamamura S; Kawakita M; Ohshima Y
    J Microbiol Immunol Infect; 2016 Oct; 49(5):813-816. PubMed ID: 25649486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical Characteristics and Prognostic Analysis of 59 Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Syndrome].
    Zhou YL; Li F; Zhang RY; Chen ZW; Zhong N; Tang WP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):657-662. PubMed ID: 32319412
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Spectrum of neuroradiological manifestations in primary hemophagocytic lymphohistiocytosis: a comparative study of EBV-induced versus non-EBV-induced forms in 75 genetically confirmed pediatric cases.
    Charpentier H; Roux CJ; Leroux P; Briand C; Levy R; Dangouloff-Ros V; Desguerre I; Neven B; Moshous D; Boddaert N
    Eur Radiol; 2023 Oct; 33(10):7149-7159. PubMed ID: 37171488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic scoring system for pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis based on baseline characteristics: A multicenter retrospective study.
    Kong Q; Li M; Wang J; Wu L; Zhou D; Yang M; Xu X; Tan Z; Wu X; Wang Z
    Pediatr Blood Cancer; 2024 Feb; 71(2):e30772. PubMed ID: 37974392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Profiling of EBV-Encoded microRNAs in EBV-Associated Hemophagocytic Lymphohistiocytosis.
    Zhou C; Xie Z; Gao L; Liu C; Ai J; Zhang L; Shen K
    Tohoku J Exp Med; 2015 Oct; 237(2):117-26. PubMed ID: 26423217
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An analysis of sintilimab combined with ruxolitinib as compassionate therapy for 12 adults with EBV-associated hemophagocytic lymphohistiocytosis.
    Xu Y; Li W; Gan J; He X; Huang X
    Ann Hematol; 2023 Dec; 102(12):3325-3333. PubMed ID: 37787838
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokine profiles in children with primary Epstein-Barr virus infection.
    Wada T; Muraoka M; Yokoyama T; Toma T; Kanegane H; Yachie A
    Pediatr Blood Cancer; 2013 Jul; 60(7):E46-8. PubMed ID: 23382108
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China.
    Shao X; Xu Y; Xu X; Xu Y; Chen H; Hong M; Liu L
    Isr Med Assoc J; 2018 Feb; 20(2):80-85. PubMed ID: 29431300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
    Jin Z; Wang Y; Wei N; Wang Z
    Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhancing diagnostic precision in EBV-related HLH: a multifaceted approach using
    Yang X; Lu X; Feng L; Wang W; Kan Y; Zhang S; Li X; Yang J
    Cancer Imaging; 2024 Aug; 24(1):108. PubMed ID: 39155389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resolution of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis associated with rapid immune reconstruction after a single course of CHOP therapy.
    Chikagawa Y; Hikishima K; Mizumaki H; Sugimori C; Nakagishi Y; Yachie A; Nakao S
    Int J Hematol; 2020 Dec; 112(6):889-893. PubMed ID: 32725606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol.
    Yanagaisawa R; Matsuda K; Ohga S; Kanegane H; Morimoto A; Okamoto Y; Ohara A; Fukushima K; Sotomatsu M; Nomura K; Saito AM; Horibe K; Ishii E; Nakazawa Y
    Int J Hematol; 2019 May; 109(5):612-617. PubMed ID: 30788725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
    Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
    Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparison of Th1/Th2 cytokine profiles between primary and secondary haemophagocytic lymphohistiocytosis.
    Chen Y; Wang Z; Luo Z; Zhao N; Yang S; Tang Y
    Ital J Pediatr; 2016 May; 42(1):50. PubMed ID: 27209435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.